Solid-Phase Peptide Synthesis (SPPS): How a Research Peptide Is Built

Before the early 1960s, peptides were assembled in solution. Each amide bond required isolating, purifying and characterizing the intermediate before moving on. Beyond five or six residues, yields collapsed and the workflow became impractical for most labs.

In 1963 Bruce Merrifield, at Rockefeller University, published a tetrapeptide synthesized on an insoluble resin in the Journal of the American Chemical Society. The idea was counterintuitive: anchor the C-terminal residue to a polymer, drive each coupling close to completion with large excesses of reagent, then filter and wash everything else away. Reception was hostile at first — one reviewer called it 'a travesty, not chemistry at all' — but reproducibility and speed eventually won. Merrifield received the Nobel Prize in Chemistry in 1984.

SPPS now underpins essentially all research-scale peptide production: hormone analogues, protein fragments, preclinical tool compounds. Solution-phase chemistry still has a place at very large industrial scale, but for the research-use peptides discussed in modern preclinical literature, SPPS is the default.

Every amino acid has an amino group (NH2) and a carboxyl group (COOH). To couple them in the right order, the incoming residue's α-amino must be temporarily masked so only its carboxyl reacts. The Fmoc/Boc distinction lives in which mask is used and how it is removed.

The Boc strategy — Merrifield's original — uses tert-butoxycarbonyl on the α-amino, removed each cycle with trifluoroacetic acid. Side chains are typically protected with benzyl-type groups, and the final cleavage from resin uses anhydrous hydrogen fluoride (HF), an aggressive reagent that requires specialized equipment.

The Fmoc strategy (9-fluorenylmethoxycarbonyl) changes the game: the α-amino comes off with a mild base — typically 20% piperidine in DMF — and only the final cleavage uses TFA. This 'base-labile / acid-labile' split is gentle on acid-sensitive residues like tryptophan and methionine and integrates cleanly with automated synthesizers. For research peptides in 2026, Fmoc/tBu chemistry is the default in nearly every academic and commercial lab.

The resin is not an inert support. The linker between peptide and polymer dictates what functional group sits at the C-terminus once the final cleavage is done. Peptides ending in a free acid (–COOH) are typically built on Wang resin, a polystyrene bead with a 4-hydroxybenzyl alcohol linker. Peptides ending in a C-terminal amide (–CONH2) — common in biologically active sequences — are built on Rink amide.

Both are acid-labile and release the peptide on TFA treatment. The choice is functional, not stylistic: the target sequence dictates the resin. Other linkers like 2-chlorotrityl chloride allow cleavage under mild conditions while keeping side-chain protections intact, useful for generating protected fragments for later ligation.

Resin loading, expressed in mmol/g, controls scale and yield. High loading delivers more peptide per gram of resin but can promote inter-chain aggregation during synthesis, lowering coupling efficiency in hydrophobic or β-sheet-prone sequences. Many groups use lower-loading resins (0.2–0.4 mmol/g) for difficult sequences.

Amide bond formation does not happen spontaneously at room temperature. The carboxyl must be activated. Modern reagents generate a reactive intermediate — typically an OBt or OAt active ester — that reacts quickly with the free amine on the growing peptide.

HBTU and HATU are uronium salts derived from HOBt and HOAt respectively. HATU is faster and racemizes the α-carbon less, which matters for problematic residues like histidine, cysteine and N-methylated amino acids. HBTU is cheaper and adequate for most standard sequences. DIC (diisopropylcarbodiimide) with HOBt remains a robust alternative, especially in flow chemistry and prolonged couplings.

Each cycle typically uses 3–5 equivalents of activated amino acid and finishes in 30–60 minutes at room temperature, or in a few minutes with microwave activation. Difficult positions get double couplings. A Kaiser test (ninhydrin colorimetric) flags residual free amines before the next residue is added, catching incomplete couplings early.

Once the full sequence sits on the resin, one step remains: cut the peptide off the support while simultaneously stripping every side-chain protecting group. The tool is a TFA-based cocktail, typically 85–95% TFA with the balance made up of scavengers — water, triisopropylsilane (TIS), ethanedithiol (EDT) or phenol depending on the residues present.

Scavengers are not optional. They quench the carbocations released during deprotection, which would otherwise covalently modify sensitive residues like Trp, Tyr, Met and Cys. A common 'Reagent K' is TFA/water/EDT/thioanisole/phenol; for cysteine-free peptides TFA/TIS/water 95:2.5:2.5 usually suffices.

After cleavage the crude peptide is precipitated in cold diethyl ether, centrifuged and washed several times to remove TFA, scavengers and deprotection byproducts. The pellet is redissolved in water/acetonitrile or aqueous acetic acid and loaded onto a reversed-phase preparative HPLC column — typically C18 — with linear acetonitrile/water gradients buffered with 0.1% TFA. Typical isolated yields for 20–30 residue peptides land in the 20–50% range, heavily sequence-dependent. Each batch is characterized by analytical HPLC and mass spectrometry before release for research use.

Three numbers matter when evaluating a research peptide. First, analytical HPLC purity: ≥98% is a reasonable bar for in vitro work, and many groups require ≥99% for animal-model studies. Second, identity by mass spectrometry: the observed monoisotopic mass should match the theoretical mass within instrument error.

Third, net peptide content. After purification, peptides come out as trifluoroacetate salts and absorb water. Gross weight is not active peptide weight. Quantitative amino acid analysis or UV quantitation at chromophoric residues (Trp, Tyr) corrects for this; without that correction, nominal concentrations in cell assays can be overstated by 20–30%.

SPPS is still evolving in 2026: continuous-flow synthesizers, microwave activation, and new resins or backbone protections that suppress aspartimide formation in Asp-Gly and Asp-Ser sequences. But Merrifield's core logic — anchor, couple, wash, repeat — remains intact six decades on.